These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

95 related articles for article (PubMed ID: 24393354)

  • 1. Replication of enhanced carbonyl stress in a subpopulation of schizophrenia.
    Miyashita M; Arai M; Yuzawa H; Niizato K; Oshima K; Kushima I; Hashimoto R; Fukumoto M; Koike S; Toyota T; Ujike H; Arinami T; Kasai K; Takeda M; Ozaki N; Okazaki Y; Yoshikawa T; Amano N; Miyata T; Itokawa M
    Psychiatry Clin Neurosci; 2014 Jan; 68(1):83-4. PubMed ID: 24393354
    [No Abstract]   [Full Text] [Related]  

  • 2. Carbonyl stress and schizophrenia.
    Arai M; Miyashita M; Kobori A; Toriumi K; Horiuchi Y; Itokawa M
    Psychiatry Clin Neurosci; 2014 Sep; 68(9):655-65. PubMed ID: 24995521
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Enhanced carbonyl stress in a subpopulation of schizophrenia.
    Arai M; Yuzawa H; Nohara I; Ohnishi T; Obata N; Iwayama Y; Haga S; Toyota T; Ujike H; Arai M; Ichikawa T; Nishida A; Tanaka Y; Furukawa A; Aikawa Y; Kuroda O; Niizato K; Izawa R; Nakamura K; Mori N; Matsuzawa D; Hashimoto K; Iyo M; Sora I; Matsushita M; Okazaki Y; Yoshikawa T; Miyata T; Itokawa M
    Arch Gen Psychiatry; 2010 Jun; 67(6):589-97. PubMed ID: 20530008
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Significance of measurements of peripheral carbonyl stress markers in a cross-sectional and longitudinal study in patients with acute-stage schizophrenia.
    Katsuta N; Ohnuma T; Maeshima H; Takebayashi Y; Higa M; Takeda M; Nakamura T; Nishimon S; Sannohe T; Hotta Y; Hanzawa R; Higashiyama R; Shibata N; Arai H
    Schizophr Bull; 2014 Nov; 40(6):1366-73. PubMed ID: 24448481
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Characterization of modified proteins in plasma from a subtype of schizophrenia based on carbonyl stress: Protein carbonyl is a possible biomarker of psychiatric disorders.
    Koike S; Kayama T; Arai M; Horiuchi Y; Kobori A; Miyashita M; Itokawa M; Ogasawara Y
    Biochem Biophys Res Commun; 2015 Nov; 467(2):361-6. PubMed ID: 26431870
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Clinical features of schizophrenia with enhanced carbonyl stress.
    Miyashita M; Arai M; Kobori A; Ichikawa T; Toriumi K; Niizato K; Oshima K; Okazaki Y; Yoshikawa T; Amano N; Miyata T; Itokawa M
    Schizophr Bull; 2014 Sep; 40(5):1040-6. PubMed ID: 24062594
    [TBL] [Abstract][Full Text] [Related]  

  • 7. [Measurement of plasma pentosidine and the clinical significance in diagnosis of diabetic nephropathies].
    Sanaka T; Hosokawa T
    Nihon Rinsho; 2005 Jun; 63 Suppl 6():373-8. PubMed ID: 15999737
    [No Abstract]   [Full Text] [Related]  

  • 8. Pyridoxamine: A novel treatment for schizophrenia with enhanced carbonyl stress.
    Itokawa M; Miyashita M; Arai M; Dan T; Takahashi K; Tokunaga T; Ishimoto K; Toriumi K; Ichikawa T; Horiuchi Y; Kobori A; Usami S; Yoshikawa T; Amano N; Washizuka S; Okazaki Y; Miyata T
    Psychiatry Clin Neurosci; 2018 Jan; 72(1):35-44. PubMed ID: 29064136
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Endogenous secretory receptor for advanced glycation endproducts levels are correlated with serum pentosidine and CML in patients with type 1 diabetes.
    Miura J; Yamamoto Y; Osawa M; Watanabe T; Yonekura H; Uchigata Y; Yamamoto H; Iwamoto Y
    Arterioscler Thromb Vasc Biol; 2007 Jan; 27(1):253-4. PubMed ID: 17185626
    [No Abstract]   [Full Text] [Related]  

  • 10. [Schizophrenia and carbonyl stress].
    Arai M; Miyashita M; Ichikawa T; Itokawa M
    Seishin Shinkeigaku Zasshi; 2012; 114(2):101-7. PubMed ID: 22568112
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Influence of hemodialysis membrane type on pentosidine plasma level, a marker of "carbonyl stress".
    Jadoul M; Ueda Y; Yasuda Y; Saito A; Robert A; Ishida N; Kurokawa K; Van Ypersele De Strihou C; Miyata T
    Kidney Int; 1999 Jun; 55(6):2487-92. PubMed ID: 10354298
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Carbonyl stress and long-term uremic complications.
    Miyata T; Kurokawa K; van Ypersele de Strihou C
    Adv Nephrol Necker Hosp; 1998; 28():311-9. PubMed ID: 9889996
    [No Abstract]   [Full Text] [Related]  

  • 13. Circulating levels and dietary intake of the advanced glycation end-product marker carboxymethyl lysine in chronic kidney disease patients on conservative predialysis therapy: a pilot study.
    Piroddi M; Palazzetti I; Quintaliani G; Pilolli F; Montaldi M; Valentina V; Libetta C; Galli F
    J Ren Nutr; 2011 Jul; 21(4):329-39. PubMed ID: 21193322
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Increased pentosidine, an advanced glycation end product, in plasma and synovial fluid from patients with rheumatoid arthritis and its relation with inflammatory markers.
    Miyata T; Ishiguro N; Yasuda Y; Ito T; Nangaku M; Iwata H; Kurokawa K
    Biochem Biophys Res Commun; 1998 Mar; 244(1):45-9. PubMed ID: 9514872
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Association of plasma pentosidine concentrations with renal function in kidney graft recipients.
    Slowik-Zylka D; Safranow K; Dziedziejko V; Ciechanowski K; Chlubek D
    Clin Transplant; 2010; 24(6):839-47. PubMed ID: 20030678
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Formation of advanced glycosylation end products and oxidative stress in young patients with type 1 diabetes.
    Tsukahara H; Sekine K; Uchiyama M; Kawakami H; Hata I; Todoroki Y; Hiraoka M; Kaji M; Yorifuji T; Momoi T; Yoshihara K; Beppu M; Mayumi M
    Pediatr Res; 2003 Sep; 54(3):419-24. PubMed ID: 12761359
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Skin advanced glycation end products as biomarkers of photosensitivity in schizophrenia.
    Tani E; Ohnuma T; Hirose H; Nakayama K; Mao W; Nakadaira M; Orimo N; Yamashita H; Takebayashi Y; Miki Y; Katsuta N; Nishimon S; Hasegawa T; Komiyama E; Suga Y; Ikeda S; Arai H
    Int J Methods Psychiatr Res; 2019 Mar; 28(1):e1769. PubMed ID: 30701623
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Increased serum concentrations of pentosidine are related to presence and severity of coronary artery disease.
    Kerkeni M; Weiss IS; Jaisson S; Dandana A; Addad F; Gillery P; Hammami M
    Thromb Res; 2014 Sep; 134(3):633-8. PubMed ID: 25065554
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Plasma advanced glycosylation end-products in maintenance haemodialysis patients.
    Odetti P; Cosso L; Pronzato MA; Dapino D; Gurreri G
    Nephrol Dial Transplant; 1995 Nov; 10(11):2110-3. PubMed ID: 8643178
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Pentosidine, carotid atherosclerosis and alterations in left ventricular geometry in hemodialysis patients.
    Zoccali C; Mallamaci F; Asahia K; Benedetto FA; Tripepi G; Tripepi R; Nicocia G; Buemi M; Miyata T
    J Nephrol; 2001; 14(4):293-8. PubMed ID: 11506253
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 5.